Last reviewed · How we verify
NCT01620814
Comparison of Intravaginal Misoprostol and Dinoprostol for the Purpose of Cervical Ripening Before Diagnostic Hysteroscopy in the Women at the Reproductive Age:RANDOMİSED,CONTROLLED PROSPECTİVE TRİAL
Phase 4 trial testing Dinoprostone in Cervical Ripening in 30 participants. Status unknown.
1 August 2012
Quick facts
| Lead sponsor | Zekai Tahir Burak Women's Health Research and Education Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 July 2012 |
| Primary completion | 1 August 2012 |
| Estimated completion | 1 September 2012 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Dinoprostone (DINOPROSTONE) — full drug profile →
- misoprostol (Misoprostol) — full drug profile →
- control
Conditions studied
- Cervical Ripening — all drugs for Cervical Ripening →
Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Who can join
Adults 20 to 35, female only, with Cervical Ripening. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
need for cervical dilatation
Time frame: 2 Months
In the all three groups, patients being necessary cervical dilatation will be determined and their rates will be calculated. -
Duration of cervical dilatation
Time frame: 2 Months
In the patients being necessary cervical dilatation, elapsed time for dilatation will be calculated.
Sponsor's own description
Comparison of intravaginal misoprostol and dinoprostol for the purpose of cervical ripening before diagnostic hysteroscopy in the women at the reproductive age:RANDOMİSED,CONTROLLED PROSPECTİVE TRİAL Objective. Comparison with one another and with control group of vaginal dinoprostol and misoprostol with for the purpose of cervical ripening before diagnostic hysteroscopy. Population: It was planned for performing to 95 women who appealed to gynecology polyclinic and will be performed diagnostic hysteroscopy. Methods: Eighty-six women who will be performed diagnostic hysteroscopy assigned as randomize to three groups. It was planned that none procedure will be applied to group 1 for cervical ripening, vaginal misoprostol and vaginal dinoprostone will be practiced to Groups 2 and 3, respectively.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Comparison of vaginal misoprostol and dinoprostone for cervical ripening before diagnostic hysteroscopy in nulliparous women.
Inal HA, Ozturk Inal ZH, Tonguc E, Var T. · · 2015 · cited 20× · PMID 25712577 · DOI 10.1016/j.fertnstert.2015.01.037 -
The use of misoprostol before hysteroscopy in Nulliparous women: a systematic review and meta-analysis of randomized controlled trials.
Salah N, Maged AM, Mahmoud SI, Bassiouny N, et al · · 2024 · cited 1× · PMID 39604937 · DOI 10.1186/s12884-024-06993-z
Verify or expand the search:
- PubMed search for NCT01620814
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dinoprostone
Trials testing the same drug.
- NCT04597333 — Labor Induction After Failed Induction With Dinoprostone. · NA · completed
- NCT04079140 — Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion · Phase 4 · completed
- NCT04080336 — Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Nulliparous Women · Phase 4 · completed
- NCT04046302 — Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women. · Phase 4 · completed
- NCT04044079 — Vaginal Dinoprostone Versus Vaginal Misoprostol Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients · Phase 4 · completed
Other recruiting trials for Cervical Ripening
Currently open trials in the same condition.
- NCT06591247 — Membrane Stripping for Cervical Ripening · NA · recruiting
- NCT07121634 — Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial · NA · active not recruiting
Other Zekai Tahir Burak Women's Health Research and Education Hospital trials
Trials by the same sponsor.
- NCT06540014 — The Difference of Weight Gain Tendencies and Obesity During Pregnancy · completed
- NCT04458441 — Can Warm Skin Disinfection Reduce the Pain Peripheral Central Catheter Application in Premature Babies? · NA · unknown
- NCT04009551 — Epidemiology, Treatment and Prognosis of Neonatal Meningitis in Turkey: A Multicenter Study · unknown
- NCT03675425 — The Effects of Phototherapy in Preterm Infants Pda · NA · unknown
- NCT03655457 — Evaluation of the Efficacy of Surfaktant in Preterm Infants by Lung Ultrasound · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01620814 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zekai Tahir Burak Women's Health Research and Education Hospital
- Last refreshed: 6 August 2012
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01620814.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing